Answers are grounded in this paper and cite their sources.
Spatial transcriptomics characterizes autophagy in ovarian carcinoma, indicating significant tumor heterogeneity.
Autophagy plays a context-dependent role in cancer, restraining tumor initiation while supporting malignant cell survival under stress. In ovarian carcinoma, autophagy has been implicated in chemoresistance and disease progression. However, its spatial organization within intact tumor tissue remains poorly understood. Here, we applied spatial transcriptomics (10x Genomics Visium) to eight primary ovarian carcinoma samples (GSE213699) to characterize the spatial distribution of autophagy-associated transcriptional activity across tumor sections. Autophagy activity exhibited pronounced spatial heterogeneity, with localized enrichment in distinct transcriptionally defined regions, supported by significant spatial clustering and regional variability. Spatial gradient analysis further indicated directional patterns of autophagy across tissue regions and areas enriched for immune-related transcriptional programs. Notably, autophagy scores showed significant associations with immune gene expression, suggesting coordinated immune–metabolic organization within the tumor microenvironment. These spatial features were further evaluated in an independent spatial transcriptomics cohort (GSE211956), demonstrating qualitative consistency of autophagy organization across datasets. Altogether, these findings highlight autophagy as a spatially dynamic feature of ovarian carcinoma, providing insight into intratumoral heterogeneity and underscoring the value of spatial transcriptomics for investigating metabolic pathways in situ.
No takes yet. Share an insight, caveat, or question.
Shriraksha et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: